Concepedia

Michelle Frascella

MF

Statistics

Publications

9

Citations

537

H-Index

9

Active since

2009

Affiliations

Amicus Therapeutics (United States)(Current)

Incyte (United States)

Michelle Frascella is an author at Amicus Therapeutics (United States) specializing in biochemistry, life sciences, and enzymology.

Publications per year

2009–2023

9

Publications

9

The Pharmacological Chaperone 1-Deoxygalactonojirimycin Reduces Tissue Globotriaosylceramide Levels in a Mouse Model of Fabry Disease

Richie Khanna, Rebecca Soska, Yi Lun et al. · Molecular Therapy · 2009 · 140 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice

Elfrida R. Benjamin, Richie Khanna, Adriane Schilling et al. · Molecular Therapy · 2012 · 93 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease

Richie Khanna, John J. Flanagan, Jessie Feng et al. · PLoS ONE · 2012 · 83 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Improved efficacy of a next-generation ERT in murine Pompe disease

Su Xu, Yi Lun, Michelle Frascella et al. · JCI Insight · 2019 · 82 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease

Richie Khanna, Allan Powe, Yi Lun et al. · PLoS ONE · 2014 · 39 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

1–5 of 9